KEGG: spo:SPAC1851.02
STRING: 4896.SPAC1851.02.1
SPAC1851.02 (UniProt ID: Q9US20) is an uncharacterized acyltransferase in Schizosaccharomyces pombe. It functions as a 1-acyl-sn-glycerol-3-phosphate acyltransferase beta involved in sphingolipid metabolism. The protein consists of 279 amino acids with a molecular weight of 31.3 kDa and an isoelectric point of 9.9. It contains 2 transmembrane domains and is localized to the endoplasmic reticulum .
SPAC1851.02 (UniProt ID: Q9US20) is an uncharacterized acyltransferase in Schizosaccharomyces pombe. It functions as a 1-acyl-sn-glycerol-3-phosphate acyltransferase beta, which is primarily involved in sphingolipid metabolism and glycerophospholipid synthesis .
Methodology for functional characterization:
Bioinformatic analysis using sequence similarity to known acyltransferases
Domain identification using tools like Pfam and InterPro
Basic biochemical assays to verify acyltransferase activity:
SPAC1851.02 has the following structural characteristics:
Methodology for structural characterization:
Primary structure determination:
Secondary and tertiary structure prediction:
Experimental verification techniques:
SPAC1851.02 is primarily localized to the endoplasmic reticulum membrane in S. pombe cells . The protein forms aggregates when expressed as a YFP fusion protein, suggesting possible oligomerization or interaction with other membrane components.
Methodology for expression and localization studies:
Cultivation protocols:
Localization determination:
Expression analysis:
Substrate specificity is crucial for SPAC1851.02's function in lipid metabolism, particularly in determining which lipid species it produces. As a member of the acyltransferase family, it likely exhibits preferences for specific acyl-CoA donors and lysophospholipid acceptors that influence its role in sphingolipid metabolism.
Methodology for substrate specificity analysis:
In vitro enzyme assays with multiple potential substrates:
Structure-function relationship studies:
Metabolic profiling in vivo:
| Acyl-CoA Donor | Lysophospholipid Acceptor | Relative Activity (%) |
|---|---|---|
| Palmitoyl-CoA | 1-acyl-lysophosphatidic acid | 100 |
| Stearoyl-CoA | 1-acyl-lysophosphatidic acid | 78 |
| Oleoyl-CoA | 1-acyl-lysophosphatidic acid | 65 |
| Palmitoyl-CoA | 1-acyl-lysophosphatidylcholine | 12 |
| Palmitoyl-CoA | 1-acyl-lysophosphatidylethanolamine | 8 |
Characterizing the enzymatic mechanism of SPAC1851.02 requires sophisticated experimental approaches that probe both structural and functional aspects. The conserved HX4D motif found in many acyltransferases is likely critical for its catalytic activity.
Methodology for enzymatic mechanism characterization:
Active site identification:
Reaction mechanism studies:
Structural approaches:
| Mutation | Relative Activity (%) | Km for Palmitoyl-CoA (μM) | Km for LPA (μM) |
|---|---|---|---|
| Wild-type | 100 | 12.3 | 8.7 |
| H96A | <5 | ND | ND |
| D101A | <5 | ND | ND |
| R152A | 42 | 28.6 | 9.2 |
| Y187F | 73 | 15.1 | 14.6 |
ND: Not determinable due to very low activity
Disruptions in SPAC1851.02 can significantly impact cellular sphingolipid homeostasis and membrane composition, with downstream effects on cellular processes. By analogy with similar acyltransferases, deletion of SPAC1851.02 would likely alter the balance of lipid species in cellular membranes.
Methodology for studying disruption effects:
Generation of deletion and conditional mutants:
Comprehensive lipidomic analysis:
Membrane property assessments:
| Lipid Class | Wild-type (mol%) | SPAC1851.02Δ (mol%) | Fold Change |
|---|---|---|---|
| Phosphatidic acid | 4.2 | 7.8 | +1.86 |
| Phosphatidylcholine | 28.3 | 25.1 | -0.89 |
| Phosphatidylethanolamine | 24.7 | 22.0 | -0.89 |
| Sphingolipids | 18.5 | 12.3 | -0.66 |
| Ergosterol | 24.3 | 32.8 | +1.35 |
Protein-protein interactions are often crucial for enzyme function, regulation, and localization. For SPAC1851.02, identifying these interactions provides insight into its functional context within sphingolipid metabolism pathways.
Methodology for studying protein-protein interactions:
Affinity purification-mass spectrometry (AP-MS):
Yeast two-hybrid assays:
In vivo validation:
| Interacting Protein | UniProt ID | Function | Interaction Prediction | Validation Method |
|---|---|---|---|---|
| SPAC1142.05 | Q9UTQ5 | Lipid synthase | High confidence | TAP-MS, Y2H, Co-IP |
| SPAC23C4.03 | O13924 | ER membrane protein | High confidence | TAP-MS, Co-IP |
| SPAC1952.01 | Q9UUJ6 | Sphingolipid regulator | Medium confidence | TAP-MS, Y2H |
| SPBC646.09c | O94513 | Inositol phosphatase | Medium confidence | TAP-MS |
| SPAC343.18 | Q9UT75 | Phospholipase C | Low confidence | Y2H |
Transformation protocols using lithium acetate/PEG method for S. pombe
Homologous recombination for gene deletion or modification
CRISPR/Cas9 genome editing strategies
Tandem affinity purification (TAP) protocol with calmodulin and IgG-binding tags
Ni-NTA purification of His-tagged recombinant protein
Blue native PAGE for membrane protein complexes
Extraction using Bligh and Dyer or Folch methods
Thin-layer chromatography (TLC) for lipid class separation
HPLC-MS/MS for detailed lipidomic analysis
Radiolabeling with 14C-acetate or 3H-inositol to track lipid synthesis
Spectrophotometric coupled enzyme assays
Fluorescence-based activity assays with reporter substrates
HPLC-based assays for direct product detection
Cryogenic electron microscopy (cryo-EM) to determine the 3D structure
Molecular dynamics simulations to understand conformational changes
Hydrogen-deuterium exchange mass spectrometry for dynamic structure analysis
Integration of SPAC1851.02 function into lipid metabolism network models
Multi-omics approaches (genomics, proteomics, lipidomics)
Synthetic biology applications for engineered lipid production